Kyle Bass’ IPR Challenges Could See Some Success Due to Nature of Patents Challenged - Analysis
May 8, 2015
Hamish McDougall and Jennifer C. Smith-Parker
Axinn Counsel Stacie Ropka was quoted in the BioPharm Insight article, "Kyle Bass’ IPR Challenges Could See Some Success Due to Nature of Patents Challenged - Analysis."